Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography–linear ion trap–mass spectrometry (LC-MSn)

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Analytical and Bioanalytical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00216-011-5528-8PMID 22065349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

  2011cited by this paper
• Development of the first metabolite-based LC-MSn urine drug screening procedure-exemplified for antidepressants

  2011cited by this paper
• A comprehensive LC-MS-based quantitative analysis of fentanyl-like drugs in plasma and urine.

  2010cited by this paper
• Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.

  2010cited by this paper
• Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.

  2009cited by this paper
• An epidemic of fatal 3-methylfentanyl poisoning in Estonia

  2008cited by this paper
• Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues

  2008cited by this paper
• Studies on 1-(2-Phenethyl)-4-(N-Propionylanilino)Piperidine (Fentanyl) and Its Related Compounds: Novel Metabolites in Rat Urine Following Injection of α-Methylfentanyl, One of the Most Abused Typical Designer Drugs

  2008cited by this paper
• Blood Levels of 3-Methylfentanyl in 3 Fatal Poisoning Cases

  2006cited by this paper
• Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil.

  1997cited by this paper
• Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.

  1996cited by this paper
• Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites (Parts 1, 2, 3)

  1994cited by this paper
• Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites: Part 3 mass spectra (m/z222 to 777 amu).

  1992cited by this paper
• [Studies on structure-activity relationships and receptor binding feature for 3-methylfentanyl derivatives].

  1990cited by this paper
• China White epidemic: an eastern United States emergency department experience.

  1989cited by this paper
• Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide and N-(3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl)-N-phenylpropanamide.

  1974cited by this paper
• The metabolism and excretion of the analgesic fentanyl (R 4263) by wistar rats

  1968cited by this paper

• Extension of the Temporal Window for the Determination of Alpha-Methylthiofentanyl and Thiofentanyl in Rat Urine by Monitoring the Metabolite Norfentanyl Using Online Solid-Phase Extraction (SPE) Coupled with Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry (UHPLC–MS/MS)

  2022cites this paper
• In Vitro and In Vivo Analysis of Fentanyl and Fentalog Metabolites using Hyphenated Chromatographic Techniques: A Review.

  2021cites this paper
• Suspect Screening of Fentanyl Analogs Using Matrix-Assisted Ionization and a Miniature Mass Spectrometer with a Custom Expandable Mass Spectral Library.

  2021cites this paper
• Discovering the major metabolites of the three novel fentanyl analogues 3-methylcrotonylfentanyl, furanylbenzylfentanyl, and 4-fluorocyclopropylbenzylfentanyl for forensic case work

  2021cites this paper
• Direct Coupling of Bio-SPME to Liquid Electron Ionization-MS/MS via a Modified Microfluidic Open Interface

  2020cites this paper
• A toxicological exploration of the opioid crisis

  2020cites this paper
• Are pigs a suitable animal model for in vivo metabolism studies of new psychoactive substances? A comparison study using different in vitro/in vivo tools and U-47700 as model drug.

  2020cites this paper
• Toxicokinetic studies and analytical toxicology of the new synthetic opioids cyclopentanoyl-fentanyl and tetrahydrofuranoyl-fentanyl.

  2020cites this paper
• In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.

  2019cites this paper
• Metabolic Pathways and Potencies of New Fentanyl Analogs

  2019influential citation
• Ten Years of Fentanyl-like Drugs: a Technical-analytical Review

  2019cites this paper
• The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology

  2019cites this paper
• Novel synthetic opioids: A review of the literature

  2019cites this paper
• Studies on the in vitro and in vivo metabolism of the synthetic opioids U-51754, U-47931E, and methoxyacetylfentanyl using hyphenated high-resolution mass spectrometry

  2019cites this paper
• Unique Structural/Stereo-Isomer and Isobar Analysis of Novel Fentanyl Analogues in Postmortem and DUID Whole Blood by UHPLC-MS-MS.

  2019cites this paper
• Benzoylfentanyl and parafluorobutyrfentanyl: Some analytical and metabolism data

  2019cites this paper
• Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700

  2018cites this paper
• Paper spray mass spectrometry for the direct, semi-quantitative measurement of fentanyl and norfentanyl in complex matrices.

  2018cites this paper
• Fatality involving ocfentanil documented by identification of metabolites.

  2018cites this paper
• Drug Interactions With New Synthetic Opioids

  2018cites this paper
• Postmortem Toxicology of New Synthetic Opioids

  2018cites this paper
• Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).

  2017cites this paper
• In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl.

  2017cites this paper
• In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl

  2017cites this paper
• Toxicology in clinical laboratories: challenging times

  2017cites this paper
• Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project

  2017cites this paper
• Multiple stage MS in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology.

  2016cites this paper
• Time-dependent postmortem redistribution of butyrfentanyl and its metabolites in blood and alternative matrices in a case of butyrfentanyl intoxication.

  2016cites this paper
• In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.

  2016cites this paper
• Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project

  2016cites this paper
• Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project

  2015cites this paper
• [Metabolism of designer drugs. The fentanyl derivatives].

  2015cites this paper
• The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).

  2014cites this paper
• 'Psychotropics caught in a trap' - adopting a screening approach to specific needs.

  2014cites this paper
• Fragmentation pathways of 2-substituted pyrrole derivatives using electrospray ionization ion trap and electrospray ionization quadrupole time-of-flight mass spectrometry.

  2013cites this paper
• Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC–MS, LC–MSn, and LC–HR-MSn

  2013influential citation
• 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques

  2013cites this paper
• Identification of fentanyl derivatives at trace levels with nonaqueous capillary electrophoresis‐electrospray‐tandem mass spectrometry (MSn, n = 2, 3): Analytical method and forensic applications

  2012cites this paper